Sign Up Today and Learn More About Cellares Stock
Invest in or calculate the value of your shares in Cellares or other pre-IPO companies through EquityZen's platform.
Cellares Stock (CELA)
Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
About Cellares Stock
Founded
2019
Headquarters
South San Francisco, CA, US
Industries
Manufacturing, Science and Engineering, Health Care
Cellares Press Mentions
Stay in the know about the latest news on Cellares
Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel
morningstar • Sep 03, 2024
Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform
businesswire • Aug 03, 2024
An automated approach to saving lives
fastcompany • Aug 03, 2024
Cellares enters into agreement with biopharma Kite
njbiz • Jul 03, 2024
Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform
biospace • Jul 01, 2024
Cellares Management
Leadership team at Cellares
Co-Founder and CEO
Fabian Gerlinghaus
Board Member
Justin Butler
Join now and verify your accreditation status to gain access to:
- Cellares current valuation
- Cellares stock price
- Available deals in Cellares and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Cellares stock?
Accredited investors can buy pre-IPO stock in companies like Cellares through EquityZen funds. These investments are made available by existing Cellares shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cellares stock?
Shareholders can sell their Cellares stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."